<DOC>
	<DOCNO>NCT01522196</DOCNO>
	<brief_summary>The purpose study determine effectiveness A 001 infusion prevent acute chest syndrome sickle cell disease ( SCD ) subject vaso-occlusive crisis , fever , elevate serum C-reactive protein ( CRP ) .</brief_summary>
	<brief_title>A Study Varespladib Infusion Subjects With Sickle Cell Disease .</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Varespladib methyl</mesh_term>
	<criteria>Genotypes Hb SS , Hb SC , sickle β°thalassemia , sickle β+ thalassemia Pain consistent vasoocclusive crisis ( clinical judgment ) attributable cause Serum CRP ≥5.0 mg/L time screen Fever define oral temperature ≥38.0°C time screen Age ≥5 year New suspect new pulmonary infiltrate diagnose chest radiography Females nursing , pregnant intend become pregnant Renal dysfunction define creatinine level &gt; 1.2 mg/dL subject age 18 less creatinine level &gt; 1.5 mg/dL subject age 18 Hepatic dysfunction ( alanine aminotransferase [ ALT ] aspartate aminotransferase [ AST ] &gt; 3 × upper limit normal ) Acute neurologic dysfunction Any medical condition transfusion may need imminently , and/or hemoglobin &lt; 5 g/dL Red blood cell transfusion within 30 day prior screen Parenteral oral corticosteroid therapy ( inhaled steroid acceptable ) within 7 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>SCD</keyword>
</DOC>